ReviewNeuro-oncology2015

Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.

Jeffrey P MacKeigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.